Published in Biomed Rep on June 21, 2017
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol (2002) 2.99
Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76
Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol (2004) 2.72
The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter. Hum Genet (1981) 2.14
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab (2004) 2.11
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med (2005) 1.99
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab (2003) 1.88
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81
Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol (1998) 1.79
Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab (2010) 1.64
Chromosomal localization of the human placental lactogen-growth hormone gene cluster to 17q22-24. Am J Hum Genet (1982) 1.57
Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology (2002) 1.52
Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol (2005) 1.48
The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab (1988) 1.44
Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol (1997) 1.40
Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A (1999) 1.35
Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol (2006) 1.32
The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab (2000) 1.23
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) (2007) 1.22
Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol (2006) 1.16
Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab (2000) 1.13
Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol (2005) 1.12
Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol (2002) 1.11
A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab (2004) 1.08
Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. J Biol Chem (1988) 1.08
Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Horm Res (2006) 1.08
Human placental growth hormone--a review. Placenta (2002) 1.07
Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy (2004) 1.06
Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res (1993) 1.06
Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology (2001) 1.05
The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol (1994) 1.05
Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest (1989) 1.05
Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol (2006) 1.04
Endocrine regulation of feto-placental growth. Horm Res (2009) 1.04
The human placental lactogen genes: structure, function, evolution and transcriptional regulation. Endocr Rev (1991) 1.04
Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol (1997) 1.03
Growth hormone 24-h serum profiles during pregnancy--lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol (1989) 1.02
Aspects of placental growth hormone physiology. Growth Horm IGF Res (2006) 1.01
Placental hormones and fetal-placental development. Anim Reprod Sci (2004) 1.01
Human placental growth hormone. Am J Obstet Gynecol (1997) 1.00
Regulatory Actions of Insulin-like Growth Factor-binding Proteins. Trends Endocrinol Metab (1998) 0.97
Pituitary-specific repression of placental members of the human growth hormone gene family. A possible mechanism for locus regulation. J Biol Chem (1993) 0.97
Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab (2003) 0.95
Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology (2004) 0.94
Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev (2005) 0.93
Placental lactogen levels in diabetic pregnancy. Br Med J (1973) 0.91
Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol (1993) 0.91
Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med (2007) 0.91
Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab (2002) 0.89
Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology (2005) 0.89
Placental hormones and the control of fetal growth. J Clin Endocrinol Metab (2010) 0.87
Adiponectin attenuation of endocrine function within human term trophoblast cells. Endocrinology (2009) 0.87
Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight. J Clin Endocrinol Metab (2001) 0.86
Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol (1993) 0.86
Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab (1995) 0.85
Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice. Proc Natl Acad Sci U S A (1988) 0.85
Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatr Res (1992) 0.85
Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi. Cell Tissue Res (1992) 0.84
Identification of placental human growth hormone as the growth hormone-V gene expression product. J Clin Endocrinol Metab (1990) 0.84
Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction. Mol Cell Endocrinol (1999) 0.84
First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol (2006) 0.84
Does the physiological acromegaly of pregnancy benefit the fetus? Gynecol Obstet Invest (2008) 0.83
Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res (2011) 0.83
The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology (1990) 0.83
Hormonal regulation of fetal growth. Horm Res (1994) 0.83
Human growth hormone-variant is a biologically active somatogen and lactogen. Endocrinology (1991) 0.82
Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm (2005) 0.82
First trimester serum tests for Down's syndrome screening. Cochrane Database Syst Rev (2015) 0.82
Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue. Endocrinology (1991) 0.81
Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease. Gynecol Oncol (2014) 0.81
Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors. Endocrine (2007) 0.81
Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol (1998) 0.81
Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone. J Biol Chem (1990) 0.81
Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm IGF Res (2006) 0.80
Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol (1990) 0.80
Intracellular signaling by growth hormone variant (GH-V). Growth Horm IGF Res (2002) 0.80
Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Horm IGF Res (2006) 0.79
Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21. Fetal Diagn Ther (1998) 0.79
Placental growth hormone and lactogen production by perifused ovine placental explants: regulation by growth hormone-releasing hormone and glucose. Biol Reprod (2002) 0.79
Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol (2008) 0.78
Elevated placental growth factor concentrations at 11-14 weeks of gestation to predict gestational diabetes mellitus. Metabolism (2014) 0.78
Maternal serum human placental growth hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies. Prenat Diagn (2010) 0.78
Evidence for the expression of growth hormone receptors in human placenta. Biochem Biophys Res Commun (1992) 0.78
Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy. PLoS One (2012) 0.78
Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome. Fetal Diagn Ther (2008) 0.77
Maternal serum placental growth hormone at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates. J Matern Fetal Neonatal Med (2012) 0.77
Placental growth hormone, fetal growth and the IGF axis in normal and diabetic pregnancy. Curr Diabetes Rev (2009) 0.77
Placental growth hormone in Down's syndrome screening. J Matern Fetal Neonatal Med (2004) 0.77
A new nonisotopic, highly sensitive assay for the measurement of human placental growth hormone: development and clinical implications. J Clin Endocrinol Metab (2003) 0.77
Lower levels of placental growth hormone in early pregnancy in women with type 1 diabetes and large for gestational age infants. Growth Horm IGF Res (2015) 0.77
Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia. Hypertens Pregnancy (2010) 0.77
Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women's blood serum. Ginekol Pol (2013) 0.77
Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study. Int J Cancer (2014) 0.76
Placental growth hormone variant: assay and clinical aspects. Acta Paediatr Suppl (1994) 0.76
Influence of growth hormone binding protein on growth hormone estimation in different immunoassays. Scand J Clin Lab Invest (1998) 0.76